CFG
ELV icon

Carr Financial Group’s Elevance Health ELV Stock Holding History

Carr Financial Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-846
Closed -$312K – 183
2024
Q4 		$312K Sell
846
-142
-14% -$59.4K 0.1% 146
2024
Q3 		$514K Buy
988
+1
+0.1% +$534 0.15% 104
2024
Q2 		$535K Buy
987
+2
+0.2% +$1.06K 0.17% 100
2024
Q1 		$511K Hold
985
– – 0.17% 103
2023
Q4 		$464K Buy
985
+500
+103% +$231K 0.17% 98
2023
Q3 		$218K Hold
485
– – 0.09% 157
2023
Q2 		$215K Sell
485
-110
-18% -$50.7K 0.09% 166
2023
Q1 		$274K Hold
595
– – 0.12% 135
2022
Q4 		$305K Buy
+595
New +$302K 0.16% 125

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Carr Financial Group's ELV Position: Q1 2025 in Review

Carr Financial Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 846 shares — an estimated $312K sold.

Carr Financial Group first reported a position in ELV in Q4 2022 and held it in 9 quarters. The position peaked at $535K in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Carr Financial Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Carr Financial Group sold 846 Elevance Health shares in Q1 2025, an estimated $312K.
  • Carr Financial Group first reported a position in Elevance Health in Q4 2022 and held it in 9 quarters.
  • Carr Financial Group's Elevance Health position peaked at $535K in Q2 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Carr Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.